Among 10,480 cancer patients, we identified 20 individuals with HCC diagnosis of which two were PV carriers in established CPGs (BRCA1 and CHEK2; Supplementary Table S4). This evidence concerns the gene CHEK2 and hepatocellular carcinoma.